Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03170414 · ClinicalTrials.gov registry record
Observational Study of Solid Organ Transplantation Utilizing HIV-Positive Donors in HIV-Positive Recipients
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 10
- Enrollment target
NCT03170414: Completed study, sponsored by University of Minnesota.
NCT03170414 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03170414 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the safety of solid organ transplantation using HIV-positive deceased donors (liver, kidney) and HIV-positive living donors (liver) in HIV-positive recipients. HIV-positive individuals who agree to accept and receive a solid organ transplant from and HIV-positive donor will be followed to determine the safety and efficacy of this practice.
Primary Outcome
Patient survival at one year.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-06-15 |
| Est. Completion | 2023-12-01 |
What the finished NCT03170414 record still lists
NCT03170414 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03170414 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03170414 about?
NCT03170414 is a clinical study titled "Observational Study of Solid Organ Transplantation Utilizing HIV-Positive Donors in HIV-Positive Recipients". The primary objective of this study is to evaluate the safety of solid organ transplantation using HIV-positive deceased donors (liver, kidney) and HIV-positive living donors (liver) in HIV-positive recipients. HIV-positive individuals who agree to accept and receive a solid organ transplant from a...
What is the current status of trial NCT03170414?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2017-06-15. Estimated completion is 2023-12-01.
Who is sponsoring clinical trial NCT03170414?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI